Glioma Intraoperative MicroElectroCorticoGraphy

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

March 31, 2028

Conditions
GliomaEpilepsy
Interventions
DEVICE

PANAXIUM MicroECoG

The PANAXIUM microelectrode ( 4x2 cm, 6 micron-thick electrode comprising 128 electrodes (28 500 µm electrodes, 96 30 µm diameter microelectrodes organized as tetrodes and 4 reference electrodes) will be placed on the cortical surface and repositioned every 90 seconds to sample the entire exposed brain surface. During the cortical electrical stimulation mapping phase, the electrode will be left at the edge of the field to detect epileptic discharges induced by stimulation. After resection, a new recording of the residual cortical surface will be made to check for persistent electrical anomalies. In the last 10 patients, the Panaxium microECoG will be compared with a macro-electrode for clinical use.

Trial Locations (3)

75013

Hôpital Pitié Salpêtrière, Paris

75014

Centre Hospitalier Sainte-Anne, Paris

75019

Hôpital Fondation Adolphe de Rothschild, Paris

All Listed Sponsors
collaborator

PANAXIUM

UNKNOWN

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT06408428 - Glioma Intraoperative MicroElectroCorticoGraphy | Biotech Hunter | Biotech Hunter